SecSonar.com

Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Vivos Therapeutics, Inc. (VVOS) is a Medical - Devices company based in US with a market capitalization of $4.1M. Revenue grew 16.1% year-over-year and free cash flow was negative at -$17.6M. This page tracks VVOS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 109 employees · IPO Dec 11, 2020

Valuation

Valuation & price

$0.61 · as of May 23, 2026 · -91.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.82$3.61$0.40Jul 25Dec 25Jul 26Jul 7, 25$5.17Jul 9, 25$6.00Jul 11, 25$6.82Jul 15, 25$6.74Jul 17, 25$5.73Jul 21, 25$5.44Jul 23, 25$5.61Jul 25, 25$5.24Jul 29, 25$4.46Jul 31, 25$4.33Aug 4, 25$4.76Aug 6, 25$4.63Aug 11, 25$4.58Aug 13, 25$4.61Aug 15, 25$4.11Aug 19, 25$4.27Aug 21, 25$4.60Aug 25, 25$4.63Aug 27, 25$4.60Aug 29, 25$4.33Sep 3, 25$4.53Sep 5, 25$4.12Sep 9, 25$3.87Sep 11, 25$3.64Sep 16, 25$3.40Sep 18, 25$3.34Sep 22, 25$3.38Sep 24, 25$3.48Sep 26, 25$3.12Sep 30, 25$3.10Oct 2, 25$3.20Oct 6, 25$3.25Oct 8, 25$3.20Oct 10, 25$3.12Oct 14, 25$3.18Oct 16, 25$2.89Oct 21, 25$2.76Oct 23, 25$2.97Oct 27, 25$2.72Oct 29, 25$2.67Oct 31, 25$2.58Nov 4, 25$2.36Nov 6, 25$2.32Nov 10, 25$2.54Nov 12, 25$2.52Nov 14, 25$2.34Nov 18, 25$2.47Nov 20, 25$2.12Nov 25, 25$2.20Nov 28, 25$2.26Dec 2, 25$2.05Dec 4, 25$2.15Dec 8, 25$2.16Dec 10, 25$2.19Dec 12, 25$2.07Dec 16, 25$2.02Dec 18, 25$1.98Dec 22, 25$2.05Dec 24, 25$2.06Dec 29, 25$2.03Jan 2, 26$2.53Jan 6, 26$2.38Jan 8, 26$2.22Jan 12, 26$2.07Jan 14, 26$2.09Jan 16, 26$2.07Jan 21, 26$1.83Jan 23, 26$1.77Jan 27, 26$1.79Jan 29, 26$1.62Feb 2, 26$1.62Feb 4, 26$1.50Feb 9, 26$1.69Feb 11, 26$1.67Feb 13, 26$1.52Feb 18, 26$1.62Feb 20, 26$1.63Feb 24, 26$1.54Feb 26, 26$1.45Mar 2, 26$1.41Mar 4, 26$1.44Mar 6, 26$1.33Mar 10, 26$1.35Mar 12, 26$1.30Mar 17, 26$1.32Mar 19, 26$1.28Mar 23, 26$1.18Mar 25, 26$1.14Mar 27, 26$1.15Mar 31, 26$1.18Apr 2, 26$1.32Apr 7, 26$1.24Apr 9, 26$1.16Apr 13, 26$1.22Apr 15, 26$1.47Apr 17, 26$0.97Apr 22, 26$1.03Apr 24, 26$0.84Apr 28, 26$0.85Apr 30, 26$0.80May 4, 26$0.74May 6, 26$0.72May 8, 26$0.66May 12, 26$0.73May 14, 26$0.69May 18, 26$0.60May 20, 26$0.59May 22, 26$0.61May 28, 26$0.67Jun 1, 26$0.69Jun 3, 26$0.64Jun 5, 26$0.86Jun 9, 26$0.70Jun 11, 26$0.61Jun 15, 26$0.58Jun 17, 26$0.51Jun 22, 26$0.40Jun 24, 26$0.44Jun 26, 26$0.45Jul 2, 26$0.45
$0.4052-week range$6.95
Loading valuation history…

Fundamentals

Key fundamentals

$4.1M

Market cap

16.1%

Revenue growth (YoY)

60.4%

Gross margin

-$17.6M

Free cash flow (USD)

$11.5M

Net debt

104.7%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$3.8MFY 2019$11.4MFY 2020$13.1MFY 2021$16.9MFY 2022$16.0MFY 2023$13.8MFY 2024$15.0MFY 2025$17.4M
$3.8M$17.4M

Free cash flow by year

2018 → 2025

FY 2018$-6.6MFY 2019$-5.5MFY 2020$-5.8MFY 2021$-18.1MFY 2022$-20.5MFY 2023$-12.7MFY 2024$-13.3MFY 2025$-17.6M
-$6.6M-$17.6M

Gross margin by year

2021 → 2025

FY 202174.7%FY 202262.5%FY 202359.9%FY 202460.0%FY 202560.4%
74.7%60.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 20, 2026 (EPS $-0.52)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt Exchange Agreement AmendmentJun 25, 2026Filing
  • 8-K eventCollaboration AgreementJun 16, 2026Filing
  • 8-K eventProposed Rights OfferingJun 16, 2026Filing
  • 8-K eventDebt Exchange AgreementJun 8, 2026Filing
  • Quarterly report10-Q FiledMay 20, 2026Filing
  • FinancingSecurities RegistrationApr 30, 2026Filing
  • 8-K eventDelisting NoticeApr 22, 2026Filing
  • Annual report10-K FiledApr 15, 2026Filing
  • 8-K eventEarnings ReleaseApr 15, 2026Filing
  • 8-K eventSecurities Purchase AgreementApr 3, 2026Filing

Questions

Frequently asked questions

What is Vivos Therapeutics, Inc.'s market cap?

Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $4.1M.

What is VVOS's P/E ratio?

A meaningful P/E ratio is not available for VVOS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Vivos Therapeutics, Inc. last report earnings?

VVOS last reported earnings on May 20, 2026; the next date is not yet scheduled.

Are insiders buying VVOS stock?

SEC Form 4 filings show no open-market insider buys at Vivos Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

HSCS

HeartSciences Inc.

$3.6M

IINNW

Inspira Technologies Oxy B.H.N. Ltd.

$3.4M

PAVM

PAVmed Inc.

$3.3M

AIDX

20/20 Biolabs, Inc. Common Stock

$5M

TNON

Tenon Medical, Inc.

$5.1M

IVF

INVO Fertility, Inc.

$2.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.